TruScreen Group Limited (ASX:TRU)

Market Cap	14.77M
Revenue (ttm)	2.46M
Net Income (ttm)	-1.68M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,899
Average Volume	84,981
Open	0.0260
Previous Close	0.0260
Day's Range	0.0260 - 0.0270
52-Week Range	0.0130 - 0.0330
Beta	-0.24
RSI	50.28
Earnings Date	May 29, 2025

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. T...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRU

Financial Performance

In 2023, TruScreen Group's revenue was 2.60 million, an increase of 25.18% compared to the previous year's 2.08 million. Losses were -2.05 million, -14.63% less than in 2022.

Financial numbers in NZD